Monsenso signs new  contract with Psychiatric Centre of Copenhagen

Monsenso signs new contract with Psychiatric Centre of Copenhagen

Monsenso signs a new contract with the Psychiatric Centre of Copenhagen. The Monsenso digital health solution will be used to collect real-world data in the precision medicine research project “PRECISE”. 

The research project is led by Professor Michael E. Benros, head of research, Biological and Precision Psychiatry at the Copenhagen Research Centre for Mental Health at Copenhagen University Hospital and covers 100 patients with affective disorders.

Precision psychiatry initiative (PRECISE)

The purpose of the “PRECISE” study is to identify biological causes of psychiatric illnesses to identify objective markers for severe psychiatric illnesses by integrating big data from national registries and biobanks into detailed clinical data to improve clinical decision-making and treatment response. Currently, treatment options for mental illness are determined by a “one-size-fits-all” approach, resulting in an unacceptably large proportion of non-responding patients. Collecting and leveraging real-world data may enable more accurate diagnostics, prevention, and new treatment strategies. 

Real world-data collection on self-reported and behavioural data

The Monsenso digital health solution will be used to collect data on patient-reported outcomes through clinical questionnaires and daily self-assessments, as well as behavioural data from wearables. In addition, the patients will be offered in-app study information and can receive reminders about medication and consultations with their clinician.

 “We are pleased to expand our collaboration with the Psychiatric Centre of Copenhagen and proud to be contributing to the PRECISE project,” says Thomas Lethenborg, CEO of Monsenso. “Mental illness is the biggest disease burden in society in the 2020s. To reduce the burden, it is critical to leverage data to diagnose and monitor mental disorders correctly and to give the right treatment to the right patients. We are happy that the Monsenso solution can contribute to that.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Quality Assurance (QA) Engineer

Quality Assurance (QA) Engineer

MONSENSO is a passionate team dedicated to designing innovative digital health technology that helps people, care providers and societies overcome the burden of mental illness.

Modern mobile and cloud-based technologies lie at the root of the company, which was founded on the idea that large-scale collection and analysis of data can be used to provide patients, clinicians and researchers with detailed and unique insight into mental health.

We are looking for an ambitious Quality Assurance (QA) Engineer to engage in the development of the Monsenso digital health platform. As a QA Engineer, you will be responsible for the entire quality assurance of the products – from planning, creating and managing the overall Quality Planning strategy to executing automatic and manual testing.

You will be a part of our growing team of software developers, and we are looking for people with technical experience as software developer or QA engineer. You should have experience applying agile software development processes as well as state-of-art quality assurance methodology and technology.

Key responsibilities

As a QA Engineer, you will have the following responsibilities:

  • Test current products and identify deficiencies (web solution and mobile apps)
  • Participate in and support agile development processes, participate actively in refinements and create acceptance tests.
  • Setup, maintain and develop automatic testing
  • Investigate product quality in order to improve customer satisfaction
  • Be part of the Product Development team to ensure continuous QA
  • Plan, conduct and execute usability testing
  • Identify key KPIs for product quality and prepare reports and metrics to Management

Monsenso is a CE marked medical device and complies with high-quality standards, including the ISO 13485 and ISO 27001 standards. QA will be part of the overall QA processes in Monsenso. Monsenso applies a high degree of automation in QA using a suite of unit testing, integration testing, and end-to-end testing technologies. We are agile in our software development and QA processes and use scrum-based methods.

What we offer

We offer a fantastic opportunity to join a young and innovative growth company, where you have the ability to make an impact and help shape the future in an exciting field. Personal health technology and digital health solutions are booming markets worldwide, and you will be at the centre of this technology revolution. Mental health is a major burden for society needing new solutions and ways of supporting treatment, and you will contribute to reducing this burden for the benefit of society and the people affected. You will also have the opportunity to work with cutting edge mobile, cloud, and data science technology.

You should expect an informal, fast-paced environment with tremendous opportunities for personal development.

If you have any questions, please contact: CTO Morten Høgholm Pedersen, pedersen@monsenso.com

Desired Skills and Expertise

We expect the successful candidate to:

  • Hold a bachelor or master degree in computer science or software engineering.
  • Have solid experience with a variety of different testing techniques such as UI Testing, Automated Testing, Security Testing, and Test Driven Development Strategies.
  • Experience with Jira and Zephyr would be good
  • Have concrete and hands-on experience with test automation techniques and tools.
  • Have knowledge and experience of Scrum-based agile development
  • Be a highly structured person and critical thinker with problem-solving skills and a sense of details.
  • Have good communications skills – orally as well as in writing.
  • Take ownership of complex tasks and be a strong self-motivator.
  • Be fluent in English and Danish, Swedish or German

As a person, you thrive in a challenging environment, where you can see and influence the bigger picture. You bring a positive mindset and winning attitude, and you see the opportunities in all the things that are not yet in place in a young, growth company compared to an established corporation.

About Monsenso

MONSENSO is an experienced team with a proven track record of designing innovative digital health technology for mental health. We believe in mutual collaboration between patients, care providers and relatives and aim at empowering and inspiring them to engage in reaching better mental health.

MONSENSO was founded in 2014 based on extensive technological and clinical research in the use of digital technology for mental health. With a strong dedication to user-centred innovation, the MONSENSO solution was designed to be easy to use for both patients and clinicians, while at the same time utilizing advanced data collection for behavioral analysis.

Monsenso announces new chairman of the Board

Monsenso announces new chairman of the Board

Copenhagen, (April 14, 2021): Monsenso, a leading provider of digital mental health solutions, today announced the appointment of Maria Hjorth as Chairman of the Board, as replacement of Jukka Pekka Pertola, who had decided to resign to reduce his number of board seats. 

The company’s Annual General Meeting was held today, in which Maria Hjorth was elected to join the board. Immediately after the Annual General Meeting, the Board of Directors held its constituent meeting and elected Maria Hjorth as Chairman and re-elected Jakob Eyvind Bardram as Deputy Chairman.

The appointment of Maria Hjorth as chairman follows changes in January where Peter Høngaard Andensen and Jacob Hahn Michelsen were elected to the Board with the aim to further strengthen the competences and the diversity of the board.

 “Maria brings extensive experience and accomplishments from the financial sector, lately from a position as CEO at VP Securities A/S, in addition to her board experience from Trifork, May Invest Holding A/S and Asetek” says CEO Thomas Lethenborg. “Her experiences from top management, financial businesses, investor relations and M&A is a great supplement to the rest of the board”. 

The Board and the management of Monsenso would like to thank Jukka Pertola for his great efforts in supporting the management, the company in general and particularly the listing on Nasdaq First North Growth Market in 2020.

“It has been a great pleasure to have served as Chairman of the Monsenso Board of Directors,” said Jukka Pertola. “I am very proud of our accomplishments over the past years, and I am confident that with Maria’s leadership, and the changes made in January, Monsenso will continue to grow and expand it’s positive impact in driving better mental health for more people at lower cost.”

The Board of Directors now consists of Maria Hjorth (Chairman), Jakob E. Bardram (Deputy Chairman), Jeppe Ø. Øvlesen, Peter Høngaard Andersen and Jacob Hahn Michelsen. 

To read the Danish version, click here.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Peter Høngaard Andersen and Jacob Hahn Michelsen join the board of Monsenso

Peter Høngaard Andersen and Jacob Hahn Michelsen join the board of Monsenso

Monsenso – a leading provider of digital health solutions for mental health – today appointed Peter Høngaard Andersen and Jacob Hahn Michelsen to its Board of Directors.

The company’s extraordinary general meeting was held today. At the meeting, the shareholders approved the following items in accordance with the proposal stated in the notice convening the extraordinary general meeting, ref. company announcement no. 2-2021:

  1. Proposal to expand the board from 4 to 5 members.
  2. Election of members to the Board of Directors.

Thomas Knudsen resigned from the Board of Directors while Peter Høngaard Andersen and Jacob Hahn Michelsen were elected. Consequently, the Board of Directors now consists of Jukka P. Pertola (Chairman until the Annual General Meeting in 2021), Jakob E. Bardram (Deputy Chairman), Jeppe Ø. Øvlesen, Peter Høngaard Andersen and Jacob Hahn Michelsen.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso is Cyber Essentials certified

Monsenso is Cyber Essentials certified

Copenhagen, Denmark – 8th of April 2021.

Monsenso A/S, a technology leader in digital health solutions for mental health is now Cyber Essentials certified.
The Monsenso digital health solution that connects individuals and clinicians to provide optimal care received a Cyber Essentials certification demonstrating the company’s commitment to security and data protection.

Cyber Essentials is the UK Government’s answer to a safer internet space for organisations of all sizes, across all sectors. Developed and operated by the National Cyber Security Centre (NCSC), the Cyber Essentials certificate assures that essential cyber security measures are in place to protect data against cyber-attacks.

“Monsenso is committed to adhere to the highest security standards. Beyond the Cyber Essentials certification, Monsenso holds the ISO 13485 and ISO 27001 certifications, a TGA certification and class 1 CE mark. The Cyber Essentials certification demonstrates our continuous commitment to keep the data of our customers secure” says Thomas Lethenborg, CEO at Monsenso.

To read more about our data protection, download our Data management & Security fact sheet.

About Monsenso

Monsenso is an innovative technology company offering a digital health solution. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit www.monsenso.com.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
Monsenso
+45 22 70 47 24
marketing@monsenso.com